Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.3000
-0.1120 (-27.18%)
At close: Apr 2, 2025, 4:00 PM
0.2590
-0.0410 (-13.67%)
After-hours: Apr 2, 2025, 7:59 PM EDT

Processa Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-11.85-11.12-27.42-11.43-14.41
Upgrade
Depreciation & Amortization
000.790.790.8
Upgrade
Other Amortization
--0.12-0.2
Upgrade
Asset Writedown & Restructuring Costs
--7.270.38.6
Upgrade
Stock-Based Compensation
0.631.068.833.412.73
Upgrade
Other Operating Activities
0.091.390.27-0.61-0.92
Upgrade
Change in Accounts Receivable
--0.070.01-0.08
Upgrade
Change in Accounts Payable
0.57-0.020.11-0.10.25
Upgrade
Change in Other Net Operating Assets
-0.680.620.36-1.08-0.31
Upgrade
Operating Cash Flow
-11.25-8.06-9.61-8.72-3.14
Upgrade
Capital Expenditures
-0-0---
Upgrade
Investing Cash Flow
-0-0---
Upgrade
Short-Term Debt Issued
----0.7
Upgrade
Long-Term Debt Issued
----0.16
Upgrade
Total Debt Issued
----0.86
Upgrade
Long-Term Debt Repaid
-0.01----
Upgrade
Net Debt Issued (Repaid)
-0.01---0.86
Upgrade
Issuance of Common Stock
7.766.32-10.0517.1
Upgrade
Repurchase of Common Stock
-0.02-0.05-0.39-0.06-0.1
Upgrade
Other Financing Activities
----0.19-
Upgrade
Financing Cash Flow
7.736.27-0.399.817.87
Upgrade
Net Cash Flow
-3.51-1.8-9.991.0814.72
Upgrade
Free Cash Flow
-11.25-8.07-9.61-8.72-3.14
Upgrade
Free Cash Flow Per Share
-3.68-6.15-11.93-11.38-8.38
Upgrade
Cash Interest Paid
0----
Upgrade
Levered Free Cash Flow
-5.85-4.11-2.96-4.19-0.23
Upgrade
Unlevered Free Cash Flow
-5.85-4.11-3.08-4.19-0.25
Upgrade
Change in Net Working Capital
-1.06-0.680.031.16-0.23
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q